112 related articles for article (PubMed ID: 18626112)
1. A TR3/Nur77 peptide-based high-throughput fluorescence polarization screen for small molecule Bcl-B inhibitors.
Yip KW; Godoi PH; Zhai D; Garcia X; Cellitti JF; Cuddy M; Gerlic M; Chen Y; Satterthwait A; Vasile S; Sergienko E; Reed JC
J Biomol Screen; 2008 Aug; 13(7):665-73. PubMed ID: 18626112
[TBL] [Abstract][Full Text] [Related]
2. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry.
Curpan RF; Simons PC; Zhai D; Young SM; Carter MB; Bologa CG; Oprea TI; Satterthwait AC; Reed JC; Edwards BS; Sklar LA
Assay Drug Dev Technol; 2011 Oct; 9(5):465-74. PubMed ID: 21561376
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors.
Rishi V; Potter T; Laudeman J; Reinhart R; Silvers T; Selby M; Stevenson T; Krosky P; Stephen AG; Acharya A; Moll J; Oh WJ; Scudiero D; Shoemaker RH; Vinson C
Anal Biochem; 2005 May; 340(2):259-71. PubMed ID: 15840499
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms.
Qian J; Voorbach MJ; Huth JR; Coen ML; Zhang H; Ng SC; Comess KM; Petros AM; Rosenberg SH; Warrior U; Burns DJ
Anal Biochem; 2004 May; 328(2):131-8. PubMed ID: 15113688
[TBL] [Abstract][Full Text] [Related]
6. Involvement of TR3/Nur77 translocation to the endoplasmic reticulum in ER stress-induced apoptosis.
Liang B; Song X; Liu G; Li R; Xie J; Xiao L; Du M; Zhang Q; Xu X; Gan X; Huang D
Exp Cell Res; 2007 Aug; 313(13):2833-44. PubMed ID: 17543302
[TBL] [Abstract][Full Text] [Related]
7. TR3/Nur77 in colon cancer cell apoptosis.
Wilson AJ; Arango D; Mariadason JM; Heerdt BG; Augenlicht LH
Cancer Res; 2003 Sep; 63(17):5401-7. PubMed ID: 14500374
[TBL] [Abstract][Full Text] [Related]
8. Akt phosphorylates the TR3 orphan receptor and blocks its targeting to the mitochondria.
Chen HZ; Zhao BX; Zhao WX; Li L; Zhang B; Wu Q
Carcinogenesis; 2008 Nov; 29(11):2078-88. PubMed ID: 18713840
[TBL] [Abstract][Full Text] [Related]
9. Discovery and development of thiazolo[3,2-a]pyrimidinone derivatives as general inhibitors of Bcl-2 family proteins.
Zhou B; Li X; Li Y; Xu Y; Zhang Z; Zhou M; Zhang X; Liu Z; Zhou J; Cao C; Yu B; Wang R
ChemMedChem; 2011 May; 6(5):904-21. PubMed ID: 21520420
[TBL] [Abstract][Full Text] [Related]
10. Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma.
Luciano F; Krajewska M; Ortiz-Rubio P; Krajewski S; Zhai D; Faustin B; Bruey JM; Bailly-Maitre B; Lichtenstein A; Kolluri SK; Satterthwait AC; Zhang XK; Reed JC
Blood; 2007 May; 109(9):3849-55. PubMed ID: 17227826
[TBL] [Abstract][Full Text] [Related]
11. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
12. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
13. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.
Lin B; Kolluri SK; Lin F; Liu W; Han YH; Cao X; Dawson MI; Reed JC; Zhang XK
Cell; 2004 Feb; 116(4):527-40. PubMed ID: 14980220
[TBL] [Abstract][Full Text] [Related]
14. Regulation of NGFI-B/Nur77 gene expression in the rat ovary and in leydig tumor cells MA-10.
Inaoka Y; Yazawa T; Uesaka M; Mizutani T; Yamada K; Miyamoto K
Mol Reprod Dev; 2008 May; 75(5):931-9. PubMed ID: 18163434
[TBL] [Abstract][Full Text] [Related]
15. [Expression, purification and activity analyses of three Bcl-2 family proteins].
Zhu C; Li X; Li W; Shi Z; Zhou J; Wang R
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):834-41. PubMed ID: 20842855
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77.
Ferlini C; Cicchillitti L; Raspaglio G; Bartollino S; Cimitan S; Bertucci C; Mozzetti S; Gallo D; Persico M; Fattorusso C; Campiani G; Scambia G
Cancer Res; 2009 Sep; 69(17):6906-14. PubMed ID: 19671798
[TBL] [Abstract][Full Text] [Related]
17. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation by TR3 receptor, a member of the steroid receptor superfamily.
Kokontis J; Liao S; Chang C
Receptor; 1991; 1(4):261-70. PubMed ID: 1843211
[TBL] [Abstract][Full Text] [Related]
19. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists.
Rega MF; Reed JC; Pellecchia M
Bioorg Chem; 2007 Apr; 35(2):113-20. PubMed ID: 16996562
[TBL] [Abstract][Full Text] [Related]
20. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
